跳至主要内容
临床试验/NCT01791413
NCT01791413已完成1 期

Effect of Pre-operative Depo Medroxyprogesterone Acetate on Serum Anti-mullerian Hormone Level After Laparoscopic Ovarian Cystectomy of Endometriomas

Mahidol University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2012年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
40
试验地点
1
主要终点
Percentage Changes of Serum Anti-Mullerian Hormone (AMH) at 2-week and 3-month Post Operation

研究概览

简要总结

The purpose of this study is to evaluate the ovarian reserve changes after preoperative depot medroxyprogesterone acetate (DMPA) in women with ovarian endometrioma undergoing laparoscopic cystectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Healthy women 18-40 years old
  • A diagnosis of endometrioma with diameter of at least 3 cm.
  • Candidates for laparoscopic cystectomy

排除标准

  • Patients' refusal to participate
  • Not candidate for depot medroxyprogesterone acetate such as: cirrhosis, chronic kidney disease, venous thrombosis
  • Use of estrogen-suppressive drugs in the preceding 3 months, such as:
  • Oral contraceptives, GnRH analogues, Progestins, Danazol
  • Pathology report present no endometriosis

研究组 & 干预措施

depot medroxyprogesterone acetate

Active Comparator

干预措施: depot medroxyprogesterone acetate (Drug)

结局指标

主要结局

Percentage Changes of Serum Anti-Mullerian Hormone (AMH) at 2-week and 3-month Post Operation

时间窗: Within the first 2 weeks and 3 months after surgery

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Weena Krutsawad

Department of Obstetrics and Gynecology

Mahidol University

研究点 (1)

Loading locations...

相似试验

Effect of Pre-operative Depo Medroxyprogesterone... | 临床试验